The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a

Se Yeon Lee, Onju Ham, Min Ji Cha, Byeong Wook Song, Eunmi Choi, Il Kwon Kim, Woochul Chang, Soyeon Lim, Chang Youn Lee, Jun Hee Park, Jiyun Lee, Yoonjin Bae, Hyang Hee Seo, Eunhyun Choi, Yangsoo Jang, Ki Chul Hwang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Human bone marrow-derived mesenchymal stem cells (hMSCs) are an attractive candidate for cell therapy in heart disease. Low survival and incomplete electromechanical integration between resident cardiomyocytes and transplanted hMSCs remain unsolved. In order for an infarcted heart to tolerate transplantation, differentiation capacity in stem cells must be reinforced. In this study, we found that compound 56, an epidermal growth factor receptor (EGFR) inhibitor, promotes cardiogenic differentiation of hMSCs and the transplantation of hMSCs treated with compound 56 resulted in enhancement of heart functions. Furthermore, hMSCs transfected with microRNA-133a (miR-133a), which targets EGFR, were observed to express cardiac-specific markers. We also discovered that luciferase activity is exclusively decreased by targeting EGFR in hMSCs transfected with miR-133a mimic. These results suggest that EGFR plays a key role in the regulation of cardiogenic differentiation in hMSCs.

Original languageEnglish
Pages (from-to)92-99
Number of pages8
JournalBiomaterials
Volume34
Issue number1
DOIs
Publication statusPublished - 2013 Jan 1

Fingerprint

Stem cells
MicroRNAs
Mesenchymal Stromal Cells
Epidermal Growth Factor Receptor
Bone
Bone Marrow
Mesenchymal Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Epidermal Growth Factor
Luciferases
Cardiac Myocytes
Heart Diseases
Stem Cells
Transplantation
Survival

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Lee, Se Yeon ; Ham, Onju ; Cha, Min Ji ; Song, Byeong Wook ; Choi, Eunmi ; Kim, Il Kwon ; Chang, Woochul ; Lim, Soyeon ; Lee, Chang Youn ; Park, Jun Hee ; Lee, Jiyun ; Bae, Yoonjin ; Seo, Hyang Hee ; Choi, Eunhyun ; Jang, Yangsoo ; Hwang, Ki Chul. / The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a. In: Biomaterials. 2013 ; Vol. 34, No. 1. pp. 92-99.
@article{9aad77ac0c3b4119a006be4c0decb0ba,
title = "The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a",
abstract = "Human bone marrow-derived mesenchymal stem cells (hMSCs) are an attractive candidate for cell therapy in heart disease. Low survival and incomplete electromechanical integration between resident cardiomyocytes and transplanted hMSCs remain unsolved. In order for an infarcted heart to tolerate transplantation, differentiation capacity in stem cells must be reinforced. In this study, we found that compound 56, an epidermal growth factor receptor (EGFR) inhibitor, promotes cardiogenic differentiation of hMSCs and the transplantation of hMSCs treated with compound 56 resulted in enhancement of heart functions. Furthermore, hMSCs transfected with microRNA-133a (miR-133a), which targets EGFR, were observed to express cardiac-specific markers. We also discovered that luciferase activity is exclusively decreased by targeting EGFR in hMSCs transfected with miR-133a mimic. These results suggest that EGFR plays a key role in the regulation of cardiogenic differentiation in hMSCs.",
author = "Lee, {Se Yeon} and Onju Ham and Cha, {Min Ji} and Song, {Byeong Wook} and Eunmi Choi and Kim, {Il Kwon} and Woochul Chang and Soyeon Lim and Lee, {Chang Youn} and Park, {Jun Hee} and Jiyun Lee and Yoonjin Bae and Seo, {Hyang Hee} and Eunhyun Choi and Yangsoo Jang and Hwang, {Ki Chul}",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2012.09.069",
language = "English",
volume = "34",
pages = "92--99",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "1",

}

Lee, SY, Ham, O, Cha, MJ, Song, BW, Choi, E, Kim, IK, Chang, W, Lim, S, Lee, CY, Park, JH, Lee, J, Bae, Y, Seo, HH, Choi, E, Jang, Y & Hwang, KC 2013, 'The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a', Biomaterials, vol. 34, no. 1, pp. 92-99. https://doi.org/10.1016/j.biomaterials.2012.09.069

The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a. / Lee, Se Yeon; Ham, Onju; Cha, Min Ji; Song, Byeong Wook; Choi, Eunmi; Kim, Il Kwon; Chang, Woochul; Lim, Soyeon; Lee, Chang Youn; Park, Jun Hee; Lee, Jiyun; Bae, Yoonjin; Seo, Hyang Hee; Choi, Eunhyun; Jang, Yangsoo; Hwang, Ki Chul.

In: Biomaterials, Vol. 34, No. 1, 01.01.2013, p. 92-99.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a

AU - Lee, Se Yeon

AU - Ham, Onju

AU - Cha, Min Ji

AU - Song, Byeong Wook

AU - Choi, Eunmi

AU - Kim, Il Kwon

AU - Chang, Woochul

AU - Lim, Soyeon

AU - Lee, Chang Youn

AU - Park, Jun Hee

AU - Lee, Jiyun

AU - Bae, Yoonjin

AU - Seo, Hyang Hee

AU - Choi, Eunhyun

AU - Jang, Yangsoo

AU - Hwang, Ki Chul

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Human bone marrow-derived mesenchymal stem cells (hMSCs) are an attractive candidate for cell therapy in heart disease. Low survival and incomplete electromechanical integration between resident cardiomyocytes and transplanted hMSCs remain unsolved. In order for an infarcted heart to tolerate transplantation, differentiation capacity in stem cells must be reinforced. In this study, we found that compound 56, an epidermal growth factor receptor (EGFR) inhibitor, promotes cardiogenic differentiation of hMSCs and the transplantation of hMSCs treated with compound 56 resulted in enhancement of heart functions. Furthermore, hMSCs transfected with microRNA-133a (miR-133a), which targets EGFR, were observed to express cardiac-specific markers. We also discovered that luciferase activity is exclusively decreased by targeting EGFR in hMSCs transfected with miR-133a mimic. These results suggest that EGFR plays a key role in the regulation of cardiogenic differentiation in hMSCs.

AB - Human bone marrow-derived mesenchymal stem cells (hMSCs) are an attractive candidate for cell therapy in heart disease. Low survival and incomplete electromechanical integration between resident cardiomyocytes and transplanted hMSCs remain unsolved. In order for an infarcted heart to tolerate transplantation, differentiation capacity in stem cells must be reinforced. In this study, we found that compound 56, an epidermal growth factor receptor (EGFR) inhibitor, promotes cardiogenic differentiation of hMSCs and the transplantation of hMSCs treated with compound 56 resulted in enhancement of heart functions. Furthermore, hMSCs transfected with microRNA-133a (miR-133a), which targets EGFR, were observed to express cardiac-specific markers. We also discovered that luciferase activity is exclusively decreased by targeting EGFR in hMSCs transfected with miR-133a mimic. These results suggest that EGFR plays a key role in the regulation of cardiogenic differentiation in hMSCs.

UR - http://www.scopus.com/inward/record.url?scp=84868131987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868131987&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2012.09.069

DO - 10.1016/j.biomaterials.2012.09.069

M3 - Article

C2 - 23069713

AN - SCOPUS:84868131987

VL - 34

SP - 92

EP - 99

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 1

ER -